tiprankstipranks
Trending News
More News >
Intellipharmaceutics International Inc. (IPCIQ)
:IPCIQ
US Market

IntelliPharmaCeutics International (IPCIQ) Income Statement

Compare
144 Followers

IntelliPharmaCeutics International Income Statement

Last quarter (Q3 2023), IntelliPharmaCeutics International's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, IntelliPharmaCeutics International's net income was $-1.89M. See IntelliPharmaCeutics International’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Nov 22Nov 21Nov 20Nov 19Nov 18
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 65.73K$ ―$ 1.40M$ 3.45M$ 1.59M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 206.06K$ 261.52K$ 415.38K$ 505.80K$ 610.38K
EBITDA
$ -2.39M$ -4.45M$ -1.97M$ -7.34M$ -12.88M
Operating Income
$ -2.85M$ -4.17M$ -4.68M$ -7.83M$ -13.33M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -2.89M$ -5.15M$ -3.39M$ -8.08M$ -13.75M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

IntelliPharmaCeutics International Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis